David Escors

ORCID

Publication Activity (10 Years)

Years Active: 2014-2024
Publications (10 Years): 34

Top Venues

International journal of molecular sciences

EMBO molecular medicine

British journal of cancer

Cancers

University College London

Centro Nacional de Biotecnología (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University College London Mar 16 2013

United Kingdom

Honorary Research Fellow :: Division of Infection and Immunity

Fundacion Miguel Servet Mar 16 2013

Spain

Principal Investigator :: Oncology

University College London Sep 01 2008 - Mar 15 2013

United Kingdom

Principal Investigator :: Division of Infection and Immunity

University College London

United Kingdom

Marie Curie Research Fellow :: Division of Infection and Immunity

University College London Feb 01 2005

United Kingdom

Post-doctoral researcher :: Division of infection and immunity

Centro Nacional de Biotecnología

Spain

Post-doctoral researcher :: Biologia celular y molecular

Centro Nacional de Biotecnología Sep 01 1997

Spain

PhD student :: Departamento de Biologia Celular y Molecular

Centro Nacional de Biotecnología Jul 01 1997 - Aug 31 1997

Spain

Graduate Student (Introduction to scientific research) :: Biologia celular y molecular

Education History

Centro Nacional de Biotecnología Jul 01 1997

Spain

PHD :: Molecular and Cellular Biology

Universidad Autonoma de Madrid Facultad de Ciencias Jul 01 1997

Spain

PHD :: Molecular and Cellular Biology

Publications

Luisa Chocarro, Ester Blanco, Leticia Fernandez-Rubio, Maider Garnica, Miren Zuazo, Maria Jesus Garcia, Ana Isabel Bocanegra, Miriam Echaide, Colette Johnston, Carolyn J Edwards, James Legg, Andrew J Pierce, Hugo Arasanz, Gonzalo Fernandez-Hinojal, Ruth Vera, Karina Ausin, Enrique Santamaria, Joaquin Fernandez-Irigoyen, Grazyna Kochan, David Escors
PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key immunotherapy targets. EMBO molecular medicine 16 (8) (2024)
Claudia Rodriguez, Luisa Chocarro, Miriam Echaide, Karina Ausin, David Escors, Grazyna Kochan
Fractalkine in Health and Disease. International journal of molecular sciences 25 (15) (2024)
Ester Blanco, Noelia Silva-Pilipich, Ana Isabel Bocanegra, Luisa Chocarro, Antonio Procopio, Karina Ausín, Joaquín Fernandez-Irigoyen, Leticia Fernández, Nerea Razquin, Ana Igea, Maider Garnica, Miriam Echaide, Hugo Arasanz, Ruth Vera, David Escors, Cristian Smerdou, Grazyna Kochan
Oleuropein-driven reprogramming of the myeloid cell compartment to sensitise tumours to PD-1/PD-L1 blockade strategies. British journal of cancer 130 (5) (2024)
Luisa Chocarro, Ester Blanco, Leticia Fernandez-Rubio, Maider Garnica, Miren Zuazo, Maria Jesus Garcia, Ana Isabel Bocanegra, Miriam Echaide, Colette Johnston, Carolyn J Edwards, James Legg, Andrew J Pierce, Hugo Arasanz, Gonzalo Fernandez-Hinojal, Ruth Vera, Karina Ausin, Enrique Santamaria, Joaquin Fernandez-Irigoyen, Grazyna Kochan, David Escors
PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key immunotherapy targets. EMBO molecular medicine 16 (8) (2024)
Ester Blanco, Noelia Silva-Pilipich, Ana Isabel Bocanegra, Luisa Chocarro, Antonio Procopio, Karina Ausín, Joaquín Fernandez-Irigoyen, Leticia Fernández, Nerea Razquin, Ana Igea, Maider Garnica, Miriam Echaide, Hugo Arasanz, Ruth Vera, David Escors, Cristian Smerdou, Grazyna Kochan
Oleuropein-driven reprogramming of the myeloid cell compartment to sensitise tumours to PD-1/PD-L1 blockade strategies. British journal of cancer (2024)
Ester Blanco, Noelia Silva-Pilipich, Ana Isabel Bocanegra, Luisa Chocarro, Antonio Procopio, Karina Ausín, Joaquín Fernandez-Irigoyen, Leticia Fernández, Nerea Razquin, Ana Igea, Maider Garnica, Miriam Echaide, Hugo Arasanz, Ruth Vera, David Escors, Cristian Smerdou, Grazyna Kochan
Oleuropein-driven reprogramming of the myeloid cell compartment to sensitise tumours to PD-1/PD-L1 blockade strategies. British journal of cancer 130 (5) (2024)
Claudia Rodriguez, Luisa Chocarro, Miriam Echaide, Karina Ausin, David Escors, Grazyna Kochan
Fractalkine in Health and Disease. International journal of molecular sciences 25 (15) (2024)
Luisa Chocarro, Ester Blanco, Leticia Fernandez-Rubio, Maider Garnica, Miren Zuazo, Maria Jesus Garcia, Ana Isabel Bocanegra, Miriam Echaide, Colette Johnston, Carolyn J Edwards, James Legg, Andrew J Pierce, Hugo Arasanz, Gonzalo Fernandez-Hinojal, Ruth Vera, Karina Ausin, Enrique Santamaria, Joaquin Fernandez-Irigoyen, Grazyna Kochan, David Escors
PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key immunotherapy targets. EMBO molecular medicine (2024)
Ester Blanco, Noelia Silva-Pilipich, Ana Isabel Bocanegra, Luisa Chocarro, Antonio Procopio, Karina Ausín, Joaquín Fernandez-Irigoyen, Leticia Fernández, Nerea Razquin, Ana Igea, Maider Garnica, Miriam Echaide, Hugo Arasanz, Ruth Vera, David Escors, Cristian Smerdou, Grazyna Kochan
Oleuropein-driven reprogramming of the myeloid cell compartment to sensitise tumours to PD-1/PD-L1 blockade strategies. British journal of cancer 130 (5) (2024)
Luisa Chocarro, Ester Blanco, Leticia Fernandez-Rubio, Maider Garnica, Miren Zuazo, Maria Jesus Garcia, Ana Isabel Bocanegra, Miriam Echaide, Colette Johnston, Carolyn J Edwards, James Legg, Andrew J Pierce, Hugo Arasanz, Gonzalo Fernandez-Hinojal, Ruth Vera, Karina Ausin, Enrique Santamaria, Joaquin Fernandez-Irigoyen, Grazyna Kochan, David Escors
PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key immunotherapy targets. EMBO molecular medicine 16 (8) (2024)
Luisa Chocarro, Ester Blanco, Leticia Fernandez-Rubio, Maider Garnica, Miren Zuazo, Maria Jesus Garcia, Ana Isabel Bocanegra, Miriam Echaide, Colette Johnston, Carolyn J Edwards, James Legg, Andrew J Pierce, Hugo Arasanz, Gonzalo Fernandez-Hinojal, Ruth Vera, Karina Ausin, Enrique Santamaria, Joaquin Fernandez-Irigoyen, Grazyna Kochan, David Escors
PD-1/LAG-3 co-signaling profiling uncovers CBL ubiquitin ligases as key immunotherapy targets. EMBO molecular medicine 16 (8) (2024)
Ester Blanco, Noelia Silva-Pilipich, Ana Isabel Bocanegra, Luisa Chocarro, Antonio Procopio, Karina Ausín, Joaquín Fernandez-Irigoyen, Leticia Fernández, Nerea Razquin, Ana Igea, Maider Garnica, Miriam Echaide, Hugo Arasanz, Ruth Vera, David Escors, Cristian Smerdou, Grazyna Kochan
Oleuropein-driven reprogramming of the myeloid cell compartment to sensitise tumours to PD-1/PD-L1 blockade strategies. British journal of cancer 130 (5) (2024)
Ester Blanco, Luisa Chocarro, Leticia Fernández-Rubio, Ana Isabel Bocanegra, Hugo Arasanz, Miriam Echaide, Maider Garnica, Sergio Piñeiro-Hermida, Grazyna Kochan, David Escors
Leading Edge: Intratumor Delivery of Monoclonal Antibodies for the Treatment of Solid Tumors. International journal of molecular sciences 24 (3) (2023)
Ester Blanco, Luisa Chocarro, Leticia Fernández-Rubio, Ana Isabel Bocanegra, Hugo Arasanz, Miriam Echaide, Maider Garnica, Sergio Piñeiro-Hermida, Grazyna Kochan, David Escors
Leading Edge: Intratumor Delivery of Monoclonal Antibodies for the Treatment of Solid Tumors. International journal of molecular sciences 24 (3) (2023)
Hugo Arasanz, Luisa Chocarro, Leticia Fernández-Rubio, Ester Blanco, Ana Isabel Bocanegra, Miriam Echaide, Ibone Labiano, Ana Elsa Huerta, Maria Alsina, Ruth Vera, David Escors, Grazyna Kochan
Current Indications and Future Landscape of Bispecific Antibodies for the Treatment of Lung Cancer. International journal of molecular sciences 24 (12) (2023)
Miriam Echaide, Luisa Chocarro de Erauso, Ana Bocanegra, Ester Blanco, Grazyna Kochan, David Escors
mRNA Vaccines against SARS-CoV-2: Advantages and Caveats. International journal of molecular sciences 24 (6) (2023)
Hugo Arasanz, Luisa Chocarro, Leticia Fernández-Rubio, Ester Blanco, Ana Isabel Bocanegra, Miriam Echaide, Ibone Labiano, Ana Elsa Huerta, Maria Alsina, Ruth Vera, David Escors, Grazyna Kochan
Current Indications and Future Landscape of Bispecific Antibodies for the Treatment of Lung Cancer. International journal of molecular sciences 24 (12) (2023)
Ana Isabel Bocanegra, Gonzalo Fernández-Hinojal, Daniel Ajona, Ester Blanco, Miren Zuazo, Maider Garnica, Luisa Chocarro, Elvira Alfaro-Arnedo, Sergio Piñeiro-Hermida, Pilar Morente, Leticia Fernández, Ana Remirez, Miriam Echaide, Maite Martinez-Aguillo, Idoia Morilla, Beatriz Tavira, Alejandra Roncero, Carolina Gotera, Alfonso Ventura, Nerea Recalde, José G Pichel, Juan Jose Lasarte, Luis Montuenga, Ruth Vera, Ruben Pio, David Escors, Grazyna Kochan
Plasma fractalkine contributes to systemic myeloid diversity and PD-L1/PD-1 blockade in lung cancer. EMBO reports (2023)
Virginia Arrazubi, Saioa Goñi, Iranzu González-Borja, Irene Hernandez-Garcia, Hugo Arasanz, Jairo Pérez-Sanz, Ana Isabel Bocanegra, Grazyna Kochan, David Escors, Yerani Ruiz de Azúa, Jesús María Elizalde, Antonio Viúdez, Ruth Vera
Circulating low density neutrophils are associated with resistance to anti-PD1 immunotherapy in squamous head and neck cancer. Head & neck (2023)
Ester Blanco, Luisa Chocarro, Leticia Fernández-Rubio, Ana Isabel Bocanegra, Hugo Arasanz, Miriam Echaide, Maider Garnica, Sergio Piñeiro-Hermida, Grazyna Kochan, David Escors
Leading Edge: Intratumor Delivery of Monoclonal Antibodies for the Treatment of Solid Tumors. International journal of molecular sciences 24 (3) (2023)
Hugo Arasanz, Luisa Chocarro, Leticia Fernández-Rubio, Ester Blanco, Ana Isabel Bocanegra, Miriam Echaide, Ibone Labiano, Ana Elsa Huerta, Maria Alsina, Ruth Vera, David Escors, Grazyna Kochan
Current Indications and Future Landscape of Bispecific Antibodies for the Treatment of Lung Cancer. International journal of molecular sciences 24 (12) (2023)
Iñigo Les, Mireia Martínez, Inés Pérez-Francisco, María Cabero, Lucía Teijeira, Virginia Arrazubi, Nuria Torrego, Ana Campillo-Calatayud, Iñaki Elejalde, Grazyna Kochan, David Escors
Predictive Biomarkers for Checkpoint Inhibitor Immune-Related Adverse Events. Cancers 15 (5) (2023)
Iñigo Les, Mireia Martínez, Inés Pérez-Francisco, María Cabero, Lucía Teijeira, Virginia Arrazubi, Nuria Torrego, Ana Campillo-Calatayud, Iñaki Elejalde, Grazyna Kochan, David Escors
Predictive Biomarkers for Checkpoint Inhibitor Immune-Related Adverse Events. Cancers 15 (5) (2023)
Miriam Echaide, Luisa Chocarro de Erauso, Ana Bocanegra, Ester Blanco, Grazyna Kochan, David Escors
mRNA Vaccines against SARS-CoV-2: Advantages and Caveats. International journal of molecular sciences 24 (6) (2023)
Miriam Echaide, Luisa Chocarro de Erauso, Ana Bocanegra, Ester Blanco, Grazyna Kochan, David Escors
mRNA Vaccines against SARS-CoV-2: Advantages and Caveats. International journal of molecular sciences 24 (6) (2023)
Anna Aiello, Mattia Emanuela Ligotti, Maider Garnica, Giulia Accardi, Anna Calabrò, Fanny Pojero, Hugo Arasanz, Ana Isabel Bocanegra, Ester Blanco, Luisa Chocarro, Miriam Echaide, Leticia Fernandez-Rubio, Pablo Ramos, Sergio Piñeiro-Hermida, Grazyna Kochan, Nahid Zareian, Farzin Farzaneh, David Escors, Calogero Caruso, Giuseppina Candore
How Can We Improve Vaccination Response in Old People? Part I: Targeting Immunosenescence of Innate Immunity Cells. International journal of molecular sciences 23 (17) (2022)
Luisa Chocarro, Ester Blanco, Leticia Fernández, Hugo Arasanz, Ana Isabel Bocanegra, Miriam Echaide, Maider Garnica, Pablo Ramos, Sergio Piñeiro-Hermida, Ruth Vera, Grazyna Kochan, David Escors
Cutting-Edge CAR Engineering: Beyond T Cells. Biomedicines 10 (12) (2022)
David Escors, Ana Isabel Bocanegra, Luisa Chocarro, Ester Blanco, Sergio Piñeiro-Hermida, Maider Garnica, Leticia Fernandez-Rubio, Ruth Vera, Hugo Arasanz, Grazyna Kochan
Systemic CD4 Immunity and PD-L1/PD-1 Blockade Immunotherapy. International journal of molecular sciences 23 (21) (2022)
Luisa Chocarro, Ester Blanco, Leticia Fernández, Hugo Arasanz, Ana Isabel Bocanegra, Miriam Echaide, Maider Garnica, Pablo Ramos, Sergio Piñeiro-Hermida, Ruth Vera, Grazyna Kochan, David Escors
Cutting-Edge CAR Engineering: Beyond T Cells. Biomedicines 10 (12) (2022)
Luisa Chocarro, Ana Isabel Bocanegra, Ester Blanco, Leticia Fernández-Rubio, Hugo Arasanz, Miriam Echaide, Maider Garnica, Pablo Ramos, Sergio Piñeiro-Hermida, Ruth Vera, David Escors, Grazyna Kochan
Cutting-Edge: Preclinical and Clinical Development of the First Approved Lag-3 Inhibitor. Cells 11 (15) (2022)
Miriam Echaide, Ibone Labiano, Marina Delgado, Angela Fernández de Lascoiti, Patricia Ochoa, Maider Garnica, Pablo Ramos, Luisa Chocarro, Leticia Fernández, Hugo Arasanz, Ana Isabel Bocanegra, Ester Blanco, Sergio Piñeiro-Hermida, Pilar Morente, Ruth Vera, Maria Alsina, David Escors, Grazyna Kochan
Immune Profiling Uncovers Memory T-Cell Responses with a Th17 Signature in Cancer Patients with Previous SARS-CoV-2 Infection Followed by mRNA Vaccination. Cancers 14 (18) (2022)
Maider Garnica, Anna Aiello, Mattia Emanuela Ligotti, Giulia Accardi, Hugo Arasanz, Ana Isabel Bocanegra, Ester Blanco, Anna Calabrò, Luisa Chocarro, Miriam Echaide, Grazyna Kochan, Leticia Fernandez-Rubio, Pablo Ramos, Fanny Pojero, Nahid Zareian, Sergio Piñeiro-Hermida, Farzin Farzaneh, Giuseppina Candore, Calogero Caruso, David Escors
How Can We Improve the Vaccination Response in Older People? Part II: Targeting Immunosenescence of Adaptive Immunity Cells. International journal of molecular sciences 23 (17) (2022)
Miren Zuazo, Hugo Arasanz, Gonzalo Fernández-Hinojal, Maria Jesus García-Granda, María Gato, Ana Bocanegra, Maite Martínez, Berta Hernández, Lucía Teijeira, Idoia Morilla, Maria Jose Lecumberri, Angela Fernández de Lascoiti, Ruth Vera, Grazyna Kochan, David Escors
Functional systemic CD4 immunity is required for clinical responses to PD-L1/PD-1 blockade therapy. EMBO molecular medicine 11 (7) (2019)
María Ibáñez-Vea, Honggang Huang, Xabier Martínez de Morentin, Estela Pérez, Maria Gato, Miren Zuazo, Hugo Arasanz, Joaquin Fernández-Irigoyen, Enrique Santamaría, Gonzalo Fernandez-Hinojal, Martin R Larsen, David Escors, Grazyna Kochan
Characterization of Macrophage Endogenous S-Nitrosoproteome Using a Cysteine-Specific Phosphonate Adaptable Tag in Combination with TiO2 Chromatography. Journal of proteome research 17 (3) (2018)
Alessio Lanna, Sian M Henson, David Escors, Arne N Akbar
The kinase p38 activated by the metabolic regulator AMPK and scaffold TAB1 drives the senescence of human T cells. Nature immunology 15 (10) (2014)

David Escors.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

David Escors